DOUBLE-STRANDED RNA AND 2′,5′-OLIGOADENYLATES: COMPANIONS IN INTERFERON ACTION?

[1]  R. Sharma,et al.  Polyamines inhibit the protein kinase 380--catalyzed phosphorylation of eukaryotic initiation factor 2 alpha. , 1982, Science.

[2]  I. Kerr,et al.  Synthesis, characterization and properties of ppp(A2'p)nApCp and related high-specific-activity 32P-labelled derivatives of ppp(A2'p)nA. , 2005, European journal of biochemistry.

[3]  R. Saneto,et al.  Dissociation of protein kinase activity and the induction of the antiviral state in a cell line responsive to the antiviral effects of interferon. , 1981, Biochemical and biophysical research communications.

[4]  C. Samuel,et al.  Mechanism of interferon action: cloned human leukocyte interferons induce protein kinase and inhibit vesicular stomatitis virus but not reovirus replication in human amnion cells. , 1981, Virology.

[5]  C. Baglioni,et al.  Structural requirements of polynucleotides for the activation of (2' - 5')An polymerase and protein kinase. , 1981, Nucleic acids research.

[6]  P. Torrence,et al.  5'-O-Monophosphoryladenylyl(2' goes to 5')adenylyl(2' goes to 5')adenosine is an antagonist of the action of 5'-O-triphosphoryladenylyl-(2' goes to 5')adenylyl(2' goes to 5')adenosine and double-stranded RNA. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Jagus,et al.  The regulation of elF-2 function during protein synthesis initiation , 1981 .

[8]  R. Friedman,et al.  Activation of human and mouse 2‐5A synthetases and mouse protein P1 kinase by nucleic acids , 1981, FEBS letters.

[9]  R. Friedman,et al.  A mouse cell line, which is unprotected by interferon against lytic virus infection, lacks ribonuclease F activity. , 1981, European journal of biochemistry.

[10]  G. Bondjers,et al.  Isolation and partial characterization of the lipoprotein families A and A-I from high-density lipoproteins of human serum. , 1981, European journal of biochemistry.

[11]  J. Justesen,et al.  The 2'5' oligoadenylate synthetase has a multifunctional 2'5' nucleotidyl-transferase activity. , 1981, Biochemical and biophysical research communications.

[12]  P. Lengyel,et al.  Interferon action: RNA cleavage pattern of a (2'-5')oligoadenylate--dependent endonuclease. , 1981, Science.

[13]  P. Doetsch,et al.  Synthesis and characterization of (2′-5′)ppp3′dA(p3′dA)n, an analogue of (2′-5′)pppA(pA)n , 1981, Nature.

[14]  T. Nilsen,et al.  Analogs of (2'-5')oligo(A). Endonuclease activation and inhibition of protein synthesis in intact cells. , 1981, The Journal of biological chemistry.

[15]  C. Baglioni,et al.  Inhibition of double-stranded ribonucleic acid activated protein kinase and 2',5'-oligo(adenylic acid) polymerase by ethidium bromide. , 1981, Biochemistry.

[16]  J. Skehel,et al.  Interferon action—sequence specificity of the ppp(A2′p)nA-dependent ribonuclease , 1981, Nature.

[17]  P. Brehm,et al.  Nonjunctional acetylcholine receptor channel open time decreases during development of Xenopus muscle , 1981, Nature.

[18]  W. Anderson,et al.  The regulation of initiation of mammalian protein synthesis. , 1981, Progress in nucleic acid research and molecular biology.

[19]  I. Kerr,et al.  Radioimmune, radiobinding and HPLC analysis of 2-5A and related oligonucleotides from intact cells , 1980, Nature.

[20]  D. Woodrow,et al.  INTERFERON‐INDUCED DISEASE IN MICE AND RATS * , 1980, Annals of the New York Academy of Sciences.

[21]  R. Friedman,et al.  Double-stranded RNA inhibits a phosphoprotein phosphatase present in interferon-treated cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Hovanessian Intracellular events in interferon-treated cells. , 1979, Differentiation; research in biological diversity.

[23]  Simon S. Jones,et al.  Chemical synthesis of 5'-O-triphosphoryladenylyl-(2' .fwdarw. 5')-adenylyl-(2' .fwdarw. 5')-adenosine (2-5A) , 1979 .

[24]  A. Zilberstein,et al.  Reversal of the interferon-induced block of protein synthesis by purified preparations of eucaryotic initiation factor 2. , 1979, Virology.

[25]  A. Zilberstein,et al.  The interferon-induced protein kinase PK-i from mouse L cells. , 1979, Journal of Biological Chemistry.

[26]  Y. Chernajovsky,et al.  An interferon-induced phosphodiesterase degrading (2'-5') oligoisoadenylate and the C-C-A terminus of tRNA. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[27]  I. Kerr,et al.  Activation of a nuclease by pppA2′p5′ A2′p5′ A in intact cells , 1979, FEBS letters.

[28]  L. Montagnier,et al.  Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Baglioni Interferon-induced enzymatic activities and their role in the antiviral state , 1979, Cell.

[30]  I. Kerr,et al.  Enzymic synthesis, characterisation and nuclear-magnetic-resonance spectra of pppA2'p5'A2'p5'A and related oligonucleotides: comparison with chemically synthesised material. , 1979, European journal of biochemistry.

[31]  C. Samuel,et al.  Mechanism of interferon action. Kinetics of interferon action in mouse L929 cells: phosphorylation of protein synthesis initiation factor elF-2 and ribosome-associated protein P1. , 1979, Virology.

[32]  C. Baglioni,et al.  Metabolic stability of 2' 5'oligo (A) and activity of 2' 5'oligo (A)-dependent endonuclease in extracts of interferon-treated and control HeLa cells. , 1979, Nucleic acids research.

[33]  C. Samuel,et al.  Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Gupta Specific protein phosphorylation in interferon-treated uninfected and virus-infected mouse L929 cells: enhancement by double-stranded RNA , 1979, Journal of virology.

[35]  P. Lengyel,et al.  Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[36]  I. Kerr,et al.  Synthesis and breakdown of pppA2'p5'A2'p5'A and transient inhibiton of protein synthesis in extracts from interferon-treated and control cells. , 1978, European journal of biochemistry.

[37]  A. Zilberstein,et al.  Interferon action: Isolation of Nuclease F, A translation inhibitor activated by interferon‐induced (2′–5′) oligo‐isoadenylate , 1978, FEBS letters.

[38]  I. Kerr,et al.  Inhibition of protein synthesis by 2′–5′ linked adenine oligonucleotides in intact cells , 1978, Nature.

[39]  B. Lebleu,et al.  Comparison of interferon action in interferon resistant and sensitive L1210 cells. , 1978, The Journal of general virology.

[40]  P. Lengyel,et al.  Interferon, double-stranded RNA, and protein phosphorylation. Characteristics of a double-stranded RNA-activated protein kinase system partially purified from interferon treated Ehrlich ascites tumor cells. , 1978, The Journal of biological chemistry.

[41]  C. Baglioni,et al.  Interferon action may be mediated by activation of a nuclease by pppA2′p5′A2′p5′A , 1978, Nature.

[42]  John A. Lewis,et al.  Dual Action of Double‐Stranded RNA in Inhibiting Protein Synthesis in Extracts of Interferon‐Treated Mouse L Cells , 1978 .

[43]  B. Williams,et al.  Inhibition of cell-free protein synthesis by pppA2′ p5′ A2′ p5′ A: a novel oligonucleotide synthesized by interferon-treated L cell extracts , 1978, Cell.

[44]  I. Kerr,et al.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[45]  P. Lengyel,et al.  Characteristics of Extracts from Interferon-treated HeLa Cells: Presence of a Protein Kinase and Endoribonuclease Activated by Double-stranded RNA and of an Inhibitor of mRNA Methylation , 1977 .

[46]  C. Samuel,et al.  Mechanism of interferon action. Kinetics of interferon action in mouse L929 cells: translation inhibition, protein phosphorylation, and messenger RNA methylation and degradation. , 1977, Virology.

[47]  P. Lengyel,et al.  Interferon, double-stranded RNA and RNA degradation. Characteristics of an endonuclease activity. , 1977, European journal of biochemistry.

[48]  Jonathan A. Cooper,et al.  Extracts of interferon-treated cells can inhibit reticulocyte lysate protein synthesis. , 1977, Biochemical and biophysical research communications.

[49]  P. Lengyel,et al.  Interferon, double-stranded RNA and mRNA degradation , 1976, Nature.

[50]  I. Gresser,et al.  Progressive glomerulonephritis in mice treated with interferon preparations at birth , 1976, Nature.

[51]  A. Zilberstein,et al.  Specific phosphorylation in vitro of a protein associated with ribosomes of interferon‐treated mouse L cells , 1976, FEBS letters.

[52]  P. Lengyel,et al.  Interferon, double-stranded RNA, and protein phosphorylation. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[53]  W. K. Roberts,et al.  Interferon-induced inhibition of protein synthesis in L-cell extracts: an ATP-dependent step in the activation of an inhibitor by double-stranded RNA. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[54]  P. Lengyel,et al.  Increased endonuclease activity in an extract from mouse Ehrlich ascites tumor cells which had been treated with a partially purified interferon preparation: dependence of double-stranded RNA;. , 1976, Biochemical and biophysical research communications.

[55]  I. Gresser,et al.  Lethality of interferon preparations for newborn mice , 1975, Nature.

[56]  I. Kerr,et al.  Increased sensitivity of cell-free protein synthesis to double-stranded RNA after interferon treatment , 1974, Nature.

[57]  D. P. Wilson,et al.  Synthesis and properties of poly 2'-fluoro-2'-deoxyuridylic acid. , 1972, Biochemical and biophysical research communications.